Page 1 of Clinical Trials for Peptide Hydrolases, 3605 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Therapy to Elevate CD4 Counts in HIV-1 Disease
Last Updated: June 8, 2011
Condition(s): HIV Disease
2
Enrolling by invitation
Extension Study of Zemaira i.v. Administration in Subjects With Emphysema Due to alpha1-proteinase Inhibitor Deficiency.
Last Updated: May 17, 2012
Condition(s): Emphysema; Alpha 1-proteinase Inhibitor Deficiency
3
Completed
The Study of HIV Protease Inhibitors and Their Effects on Glucose Metabolism
Last Updated: September 28, 2009
Condition(s): Diabetes; HIV Infections; Insulin Resistance
4
Active, not recruiting
Zemaira in Subjects With Emphysema Due to Alpha1-Proteinase Inhibitor (API) Deficiency
Last Updated: May 17, 2012
Condition(s): Alpha1-proteinase Inhibitor Deficiency; Emphysema
5
Completed
Pharmacokinetic Study of ARALAST (Human Alpha1- PI)
Last Updated: July 18, 2011
Condition(s): Alpha 1-Antitrypsin Deficiency
6
Not yet recruiting
A Study to Evaluate the Use of a Protease Inhibitor and of Interleukin-2 (IL-2) in the Treatment of Early HIV Infection
Last Updated: April 23, 2009
Condition(s): HIV Infections
7
Completed
Observational Study Of A Protease Inhibitor (PI) Containing Regimen In Subjects With PI Mutations Selected During Prior Treatment With GW433908 (Fosamprenavir)
Last Updated: March 17, 2011
Condition(s): Human Immunodeficiency Virus I Infection; HIV Infection
8
Recruiting
Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor Plus Emtricitabine/Tenofovir Fixed-Dose Combination to the Elvitegravir/Cobicistat/ Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV 1 Infected Patients
Last Updated: March 23, 2012
Condition(s): Acquired Immunodeficiency Syndrome; HIV Infections
9
Completed
BRAVO: Background Regimen of Raltegravir on Virologic Outcome
Last Updated: May 18, 2011
Condition(s): HIV Infections
10
Completed
A Study of Amprenavir in Patients With Protease Inhibitor-Related Complications
Last Updated: June 23, 2005
Condition(s): HIV Infections
11
Not yet recruiting
WOUNDCHEK™ Protease Status Point of Care (POC) Diagnostic Test on DFU
Last Updated: February 22, 2012
Condition(s): Diabetic Foot Ulcers
12
Completed
Efficacy and Safety Study of Augmentation Therapy With ARALAST Fraction IV-1 (Human Alpha 1 - Proteinase Inhibitor)
Last Updated: March 3, 2011
Condition(s): Alpha 1-Antitrypsin Deficiency
13
Completed
Dual Boosted Protease Inhibitor Regimens Without Any Additional Antiretroviral Therapy in HIV-1 Infected Patients (ANRS127)
Last Updated: December 21, 2011
Condition(s): HIV Infections
14
Recruiting
French Cohort of Therapeutic Failure and Resistances in Patients Treated With a Protease Inhibitor (Telaprevir or Boceprevir), Pegylated Interferon and Ribavirin
Last Updated: January 20, 2012
Condition(s): Chronic Hepatitis C
15
Active, not recruiting
Protease Inhibitor Monotherapy Versus Ongoing Triple-therapy in the Long Term Management of HIV Infection (PIVOT)
Last Updated: February 11, 2011
Condition(s): HIV Infection; Acquired Immunodeficiency Syndrome
16
Not yet recruiting
RhDNase and Biodistribution of PMN Serine Proteases in Cystic Fibrosis Sputum
Last Updated: February 12, 2009
Condition(s): Cystic Fibrosis
17
Active, not recruiting
Clinical Trial, Open-label, Randomised, in Order to Compare the Quality of Life for Those VIH+ Patients That Start With Monotherapy on LPV/r Tablets Vs. Triple Therapy With a Boosted Protease Inhibitor
Last Updated: July 11, 2011
Condition(s): HIV Infection
18
Active, not recruiting
Study of Protease Inhibitor Regimen Switch in HIV-1 Infected Patients With Undetectable Viral Load to Prove the Non-inferiority of Once Daily Dose Regimen Versus the Current Twice Daily Regimen to Maintain the Viral Load Under the Limit of Detection.
Last Updated: May 25, 2010
Condition(s): HIV-1 Infection; HIV Infections
19
Completed
A Study on Possible Interactions Between Protease Inhibitors (Anti-HIV Drugs) and Drugs Which Lower the Level of Fat in Your Blood
Last Updated: May 17, 2012
Condition(s): HIV Infections
20
Completed
Tipranavir/Ritonavir vs. Genotypically Defined Protease Inhibitor/Ritonavir in HIV Patients (RESIST-2)
Last Updated: May 18, 2012
Condition(s): HIV Infections

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Peptide+Hydrolases

Page 1 of Clinical Trials for Peptide Hydrolases, 3605 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About